NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

5871. Intent to exempt certain unclassified medical devices from premarket notification requirements: guidance for industry and Food and Drug Administration staff

5874. Opioid use disorder: developing depot buprenorphine products for treatment

5875. Evaluation of devices used with regenerative medicine advanced therapies

5876. Considerations for the inclusion of adolescent patients in adult oncology clinical trials

5877. Severely debilitating or life-threatening hematologic disorders: nonclinical development of pharmaceuticals

5878. Enrichment strategies for clinical trials to support determination of effectiveness of human drugs and biological products

5879. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices): guidance for industry and Food and Drug Administration staff

5880. Pediatric HIV infection: drug product development for treatment